U.S., Feb. 27 -- ClinicalTrials.gov registry received information related to the study (NCT06847750) titled 'Elastography Ultrasound in Localized Scleroderma (Morphea) Study' on Dec. 16, 2024.
Brief Summary: Localized scleroderma (LS) is a skin disease that can cause complications such as disfigurement and limitation of mobility. Treatment for LS should be initiated early in the disease, as late-stage scleroderma does not respond well to treatment. Objective tools for diagnosis and follow-up of treatment for LS are not available clinically and are urgently needed. A new non-invasive ultrasound technique called "elastography" measures stiffness of tissues and holds potential for providing objective measures for follow-up of treatment of LS ...